CAMP - CTLT BTAI and CAMP are among pre market gainers
2024-02-05 08:31:42 ET
- Chenghe Acquisition ( CHEA ) +153% .
- 4D Molecular Therapeutics ( FDMT ) +54% .
- BioRestorative Therapies ( BRTX ) +26% Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease.
- Everbridge ( EVBG ) +18% Enters into Definitive Agreement to Be Acquired by Thoma Bravo for $1.5 Billion.
- Calamp ( CAMP ) +10% .
- Reborn Coffee ( REBN ) +16% .
- Estee Lauder ( EL ) +16% Q2 earnings call release
- Adverum Biotechnologies ( ADVM ) +15% Announces $127.5 Million Private Placement Financing.
- Catalent ( CTLT ) +11% .
- MicroCloud Hologram ( HOLO ) +9% .
- Cadrenal Therapeutics ( CVKD ) +10% .
- Smart for Life ( SMFL ) +10% .
- BioXcel Therapeutics ( BTAI ) +11% .
- OneMedNet ( ONMD ) +8%
- Elanco Animal Health ( ELAN ) +8% buy Elanco’s aqua business for $1.3B in cash.
- Core Scientific ( CORZ ) +7% .
- Rani Therapeutics Holdings ( RANI ) +12% .
- Aclarion ( ACON ) +6% .
- Alto Neuroscience ( ANRO ) +6% .
- Clearmind Medicine ( CMND ) +19% .
- Tyson Foods ( TSN ) +5% rallies after smashing profit expectations despite slowing price inflation.